questionsmedicales.fr
Facteurs biologiques
Antigènes
Isoantigènes
Antigènes d'histocompatibilité
Antigènes HLA
Antigènes HLA-B
Antigène HLA-B13
Antigène HLA-B13 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Polymérase Chain Reaction
Séquençage
Maladies auto-immunes
Infections virales
Greffe d'organe
Compatibilité tissulaire
Symptômes
5
Symptômes
Maladies associées
Antigènes HLA
Maladies auto-immunes
Conditions médicales
Symptômes
Allergies
Maladies auto-immunes
Prévention
5
Mode de vie sain
Gestion du stress
Tests génétiques
Surveillance préventive
Éducation
Gestion des risques
Traitements
5
Immunosuppresseurs
Thérapies ciblées
Traitement immunologique
Antigènes HLA
Traitement
Maladies associées
Efficacité des traitements
Réponse individuelle
Thérapie génique
Recherche médicale
Complications
5
Complications
Maladies auto-immunes
Gestion des complications
Récupération
Gravité
Évolution des maladies
Complications spécifiques
Maladies associées
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Infections
Maladies auto-immunes
Tests génétiques
Évaluation médicale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-B13 : Questions médicales les plus fréquentes",
"headline": "Antigène HLA-B13 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Antigène HLA-B13 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-20",
"dateModified": "2025-02-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Antigène HLA-B13"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Antigènes HLA-B",
"url": "https://questionsmedicales.fr/mesh/D015235",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes HLA-B",
"code": {
"@type": "MedicalCode",
"code": "D015235",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.380"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-B13",
"alternateName": "HLA-B13 Antigen",
"code": {
"@type": "MedicalCode",
"code": "D059908",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Apostolos P Georgopoulos",
"url": "https://questionsmedicales.fr/author/Apostolos%20P%20Georgopoulos",
"affiliation": {
"@type": "Organization",
"name": "The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA."
}
},
{
"@type": "Person",
"name": "Lisa M James",
"url": "https://questionsmedicales.fr/author/Lisa%20M%20James",
"affiliation": {
"@type": "Organization",
"name": "The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Arie Admon",
"url": "https://questionsmedicales.fr/author/Arie%20Admon",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Biology, Technion Israel Institute of Technology, Haifa, Israel admon@technion.ac.il Michael.peled@sheba.health.gov.il."
}
},
{
"@type": "Person",
"name": "Spyros A Charonis",
"url": "https://questionsmedicales.fr/author/Spyros%20A%20Charonis",
"affiliation": {
"@type": "Organization",
"name": "The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Within-subject variation of C-reactive protein and high-sensitivity C-reactive protein: A systematic review and meta-analysis.",
"datePublished": "2024-11-01",
"url": "https://questionsmedicales.fr/article/39485740",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0304961"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of C-Reactive Protein in Diabetic Inflammation.",
"datePublished": "2022-05-17",
"url": "https://questionsmedicales.fr/article/35620114",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/3706508"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein, immunothrombosis and venous thromboembolism.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36177015",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1002652"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-Reactive Protein-to-Prealbumin and C-Reactive Protein-to-Albumin Ratios as Nutritional and Prognostic Markers in Hospitalized Patients-An Observational Study.",
"datePublished": "2024-08-08",
"url": "https://questionsmedicales.fr/article/39203747",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu16162610"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein/albumin and C-reactive protein/fibrinogen ratios for the diagnosis of periprosthetic joint infection in revision total joint arthroplasty.",
"datePublished": "2023-01-07",
"url": "https://questionsmedicales.fr/article/36623413",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2023.109682"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Antigènes",
"item": "https://questionsmedicales.fr/mesh/D000941"
},
{
"@type": "ListItem",
"position": 4,
"name": "Isoantigènes",
"item": "https://questionsmedicales.fr/mesh/D007519"
},
{
"@type": "ListItem",
"position": 5,
"name": "Antigènes d'histocompatibilité",
"item": "https://questionsmedicales.fr/mesh/D006649"
},
{
"@type": "ListItem",
"position": 6,
"name": "Antigènes HLA",
"item": "https://questionsmedicales.fr/mesh/D006680"
},
{
"@type": "ListItem",
"position": 7,
"name": "Antigènes HLA-B",
"item": "https://questionsmedicales.fr/mesh/D015235"
},
{
"@type": "ListItem",
"position": 8,
"name": "Antigène HLA-B13",
"item": "https://questionsmedicales.fr/mesh/D059908"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Antigène HLA-B13 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Antigène HLA-B13",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Antigène HLA-B13",
"description": "Comment diagnostiquer la présence de HLA-B13 ?\nQuels tests sont utilisés pour HLA-B13 ?\nHLA-B13 est-il associé à des maladies spécifiques ?\nPeut-on détecter HLA-B13 chez tous les individus ?\nQuel rôle joue HLA-B13 dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D059908?mesh_terms=C-Reactive+Protein#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Antigène HLA-B13",
"description": "Quels symptômes sont liés à HLA-B13 ?\nHLA-B13 cause-t-il des symptômes directs ?\nY a-t-il des symptômes spécifiques à HLA-B13 ?\nHLA-B13 est-il lié à des symptômes allergiques ?\nLes symptômes varient selon l'ethnicité ?",
"url": "https://questionsmedicales.fr/mesh/D059908?mesh_terms=C-Reactive+Protein#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Antigène HLA-B13",
"description": "Peut-on prévenir les maladies liées à HLA-B13 ?\nY a-t-il des mesures préventives spécifiques ?\nLa vaccination aide-t-elle contre HLA-B13 ?\nLes tests génétiques peuvent-ils prévenir des maladies ?\nL'éducation sur HLA-B13 est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D059908?mesh_terms=C-Reactive+Protein#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Antigène HLA-B13",
"description": "Quels traitements sont disponibles pour les maladies liées à HLA-B13 ?\nHLA-B13 influence-t-il le choix du traitement ?\nY a-t-il des traitements spécifiques pour HLA-B13 ?\nLes traitements sont-ils efficaces pour HLA-B13 ?\nDes thérapies géniques sont-elles envisagées pour HLA-B13 ?",
"url": "https://questionsmedicales.fr/mesh/D059908?mesh_terms=C-Reactive+Protein#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Antigène HLA-B13",
"description": "Quelles complications peuvent survenir avec HLA-B13 ?\nHLA-B13 augmente-t-il le risque de cancer ?\nLes complications sont-elles réversibles ?\nHLA-B13 influence-t-il la gravité des maladies ?\nY a-t-il des complications spécifiques à HLA-B13 ?",
"url": "https://questionsmedicales.fr/mesh/D059908?mesh_terms=C-Reactive+Protein#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Antigène HLA-B13",
"description": "Quels sont les facteurs de risque pour HLA-B13 ?\nL'ethnicité influence-t-elle HLA-B13 ?\nLes infections augmentent-elles le risque lié à HLA-B13 ?\nLe mode de vie affecte-t-il HLA-B13 ?\nY a-t-il des tests pour évaluer les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D059908?mesh_terms=C-Reactive+Protein#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la présence de HLA-B13 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin pour déterminer le typage HLA est utilisé pour diagnostiquer HLA-B13."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour HLA-B13 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de typage HLA, comme la PCR et le séquençage, sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "HLA-B13 est-il associé à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, HLA-B13 est lié à certaines maladies auto-immunes et infections virales."
}
},
{
"@type": "Question",
"name": "Peut-on détecter HLA-B13 chez tous les individus ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, HLA-B13 est présent chez une partie de la population, selon l'ethnicité."
}
},
{
"@type": "Question",
"name": "Quel rôle joue HLA-B13 dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il aide à évaluer la compatibilité pour les greffes et à identifier des risques de maladies."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à HLA-B13 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon les maladies associées, comme des douleurs articulaires ou éruptions."
}
},
{
"@type": "Question",
"name": "HLA-B13 cause-t-il des symptômes directs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, HLA-B13 lui-même ne cause pas de symptômes, mais il est associé à des maladies."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à HLA-B13 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes dépendent des conditions associées, pas de HLA-B13 directement."
}
},
{
"@type": "Question",
"name": "HLA-B13 est-il lié à des symptômes allergiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "HLA-B13 n'est pas directement lié aux allergies, mais à des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon l'ethnicité ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la prévalence de HLA-B13 et les maladies associées peuvent varier selon l'ethnicité."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées à HLA-B13 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un suivi médical régulier peut aider à détecter précocement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures préventives incluent un mode de vie sain et la gestion du stress."
}
},
{
"@type": "Question",
"name": "La vaccination aide-t-elle contre HLA-B13 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination peut aider à prévenir certaines infections, mais pas directement HLA-B13."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils prévenir des maladies ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les risques et permettre une surveillance préventive."
}
},
{
"@type": "Question",
"name": "L'éducation sur HLA-B13 est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur HLA-B13 et ses implications peut aider à mieux gérer les risques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies liées à HLA-B13 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des immunosuppresseurs et des thérapies ciblées selon la maladie."
}
},
{
"@type": "Question",
"name": "HLA-B13 influence-t-il le choix du traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de HLA-B13 peut influencer le choix des traitements immunologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques pour HLA-B13 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique pour HLA-B13, mais pour les maladies associées."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces pour HLA-B13 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité des traitements dépend de la maladie associée et de la réponse individuelle."
}
},
{
"@type": "Question",
"name": "Des thérapies géniques sont-elles envisagées pour HLA-B13 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur les thérapies géniques, mais elles ne sont pas encore disponibles."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec HLA-B13 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies auto-immunes et des réactions aux greffes."
}
},
{
"@type": "Question",
"name": "HLA-B13 augmente-t-il le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre HLA-B13 et un risque accru de certains cancers."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "HLA-B13 influence-t-il la gravité des maladies ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, HLA-B13 peut influencer la gravité et l'évolution de certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications spécifiques à HLA-B13 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications spécifiques dépendent des maladies associées, pas de HLA-B13 lui-même."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour HLA-B13 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, l'ethnicité et des infections virales."
}
},
{
"@type": "Question",
"name": "L'ethnicité influence-t-elle HLA-B13 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la prévalence de HLA-B13 varie selon les groupes ethniques et les populations."
}
},
{
"@type": "Question",
"name": "Les infections augmentent-elles le risque lié à HLA-B13 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent déclencher des maladies auto-immunes chez les porteurs de HLA-B13."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il HLA-B13 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire le risque de maladies associées à HLA-B13."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests pour évaluer les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques et des évaluations médicales peuvent aider à identifier les risques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 14/02/2025
Contenu vérifié selon les dernières recommandations médicales
7 publications dans cette catégorie
Affiliations :
The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA.
Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA.
7 publications dans cette catégorie
Affiliations :
The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA.
3 publications dans cette catégorie
Publications dans "Antigène HLA-B13" :
3 publications dans cette catégorie
Affiliations :
Faculty of Biology, Technion Israel Institute of Technology, Haifa, Israel admon@technion.ac.il Michael.peled@sheba.health.gov.il.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Centre for Inflammatory Diseases, Monash University, Clayton, Victoria, 3168, Australia; Dept. of Nephrology, Monash Health, Clayton, Victoria, 3168, Australia; Dept. of Paediatric Nephrology, Monash Health, Clayton, Victoria, 3168, Australia.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Netherlands Proteomics Centre, Utrecht University, Utrecht, Netherlands.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Netherlands Proteomics Centre, Utrecht University, Utrecht, Netherlands.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Faculty of Biology, Technion Israel Institute of Technology, Haifa, Israel.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, United States.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Janssen Research & Development, Turnhoutseweg 30, BE-2340, Beerse, Belgium.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: sferrone@mgh.harvard.edu.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Protein Biochemistry, Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany. malvaro@zedat.fu-berlin.de.
Publications dans "Antigène HLA-B13" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Protein Biochemistry, Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany. chfreund@zedat.fu-berlin.de.
Publications dans "Antigène HLA-B13" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Publications dans "Antigène HLA-B13" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States.
Publications dans "Antigène HLA-B13" :
C-reactive protein (CRP) and high-sensitivity C-reactive protein (hsCRP) are measures of inflammation used in diagnosis, to guide treatment decisions, and in disease prediction. Variability in measure...
A systematic review and meta-analysis was performed to estimate longitudinal within-subject variability of CRP and hsCRP over any time period. Follow-up studies of any design in adults or children, wi...
Of 2675 studies identified, 60 met the inclusion criteria: 34 reported CRP and 26 reported hsCRP. For CRP, median CV was 0.41 (range 0.11 to 0.89), and the pooled estimate of ICC was 0.55 (95% CI 0.35...
Assessment of variability was not the main aim of many of the included papers, and it is possible that some relevant papers have been missed. Many of the papers included had low numbers of participant...
Estimated within-subject variability is high for both CRP and hsCRP, but estimates are based on small numbers of participants and measurements. There is a need for better estimates of within-subject v...
Even though type 2 diabetes mellitus (T2DM) represents a worldwide chronic health issue that affects about 462 million people, specific underlying determinants of insulin resistance (IR) and impaired ...
C-reactive protein (CRP) is a member of the highly conserved pentraxin superfamily of proteins and is often used in clinical practice as a marker of infection and inflammation. There is now increasing...
This study aimed to evaluate the role of the C-reactive protein-to-prealbumin (CP) ratio and the C-reactive protein-to-albumin (CA) ratio as nutritional and prognostic markers. A retrospective study w...
Testing for systemic inflammation markers is considered a simpler method for diagnosing periprosthetic joint infection (PJI). Changes in the C-reactive protein/albumin ratio (CRP/Alb ratio) and C-reac...
We retrospectively evaluated 445 patients who underwent total hip and knee revision arthroplasties between January 2010 and February 2021. Of these, 129 patients were also independently evaluated for ...
The AUC values of the CRP/Alb and CRP/Fib ratios were 0.880 and 0.872, respectively, suggesting similar diagnostic potentials for PJI. The CRP/Alb and CRP/Fib ratios were better than the erythrocyte s...
Both the CRP/Alb and CRP/Fib ratios were significantly higher in patients with PJI than in those with aseptic failure and showed better sensitivity and specificity for diagnosing PJI than classical in...
The quantification of protein biomarkers in blood at picomolar-level sensitivity requires labour-intensive incubation and washing steps. Sensing proteins in sweat, which would allow for point-of-care ...
Human C-reactive protein (CRP) binds to lipophosphoglycan (LPG), a virulence factor of...
C-reactive protein (CRP) is well-recognized as a sensitive biomarker of inflammation. Association of elevations in plasma/serum CRP level with disease state has received considerable attention, even t...
In a retrospective study, we analyzed the prevalence of elevated C‑reactive protein (CRP) serum levels in 148 patients with chronic myelomonocytic leukemia (CMML), their potential prognostic impact, a...
Hypertension has become an important health risk factor in the twenty-first century, especially for the elderly. Studies have confirmed that inflammation is involved in the development of hypertension...
Serum CRP levels were measured in 196 hospitalized patients, and the CRP level was used as a criterion to divide them into the group with elevated CRP (> 10 mmol/L, n = 120) and the group with normal ...
The prevalence of hypertension, coronary artery disease and joint reactive inflammation was significantly higher in the group with elevated CRP. There was also a significant association between the us...
Elevated CRP, BMI, and diabetes are positively associated with hypertension in the elderly, and early screening for CRP and initiation of treatment may help prevent further inflammatory responses in h...